Last C$2.22 CAD
Change Today -0.01 / -0.45%
Volume 710.0
TLB On Other Exchanges
As of 3:56 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

tearlab corp (TLB) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/28/14 - C$9.09
52 Week Low
01/26/15 - C$1.92
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TEARLAB CORP (TLB)

Related News

No related news articles were found.

tearlab corp (TLB) Related Businessweek News

No Related Businessweek News Found

tearlab corp (TLB) Details

TearLab Corp. operates as an ophthalmic device company in the United States. It is involved in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company’s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California.

101 Employees
Last Reported Date: 03/17/14
Founded in 1996

tearlab corp (TLB) Top Compensated Officers

Chairman, Chief Executive Officer and Secreta...
Total Annual Compensation: $347.2K
President and Chief Operating Officer
Total Annual Compensation: $74.5K
Chief Financial Officer and Treasurer
Total Annual Compensation: $172.3K
Vice President of Regulatory
Total Annual Compensation: $180.0K
Compensation as of Fiscal Year 2013.

tearlab corp (TLB) Key Developments

TearLab Corporation Appoints Raymond Kong to its Senior Management Team as Vice President of Sales

TearLab Corporation announced the appointment of Raymond Kong to its senior management team as Vice President of Sales. Mr. Kong succeeds Duane Morrison, who will shift his focus to major accounts and doctor networks in the newly created position of Vice President of Business Development. Mr. Kong has an accomplished history of sales, marketing and general management success within the global ophthalmic industry. Most recently, he served as General Manager for Alcon Laboratories Inc.'s Indonesia business, where he had overall P&L responsibility for its surgical, pharmaceutical and consumer business segments.

TearLab Mulls Acquisitions

TearLab Corporation (NasdaqCM:TEAR) is looking for acquisitions. SMTP, Inc. has filed a shelf registration in the amount of $25 million and intends to use a portion of the net proceeds to acquire complementary products, technologies, businesses and for investment-grade, interest bearing investments.

TearLab Corporation Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 02:30 PM

TearLab Corporation Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 02:30 PM. Venue: The Westin Grand Central, New York, New York, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TLB:CN C$2.22 CAD -0.01

TLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TLB.
View Industry Companies

Industry Analysis


Industry Average

Valuation TLB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.3x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEARLAB CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at